Stroke Market Report 2025

The stroke market size has grown rapidly in recent years. It will grow from $35.92 billion in 2024 to $39.72 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historical period is driven by the rising prevalence of cardiovascular diseases, an expanding elderly population, improved awareness of stroke symptoms, development of hospital infrastructure, and enhanced government support initiatives.

The stroke market size is expected to see rapid growth in the next few years. It will grow to $58.81 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The anticipated growth during the forecast period is driven by the increasing use of telemedicine, rising demand for minimally invasive treatments, greater emphasis on early diagnosis, expanding healthcare access in emerging markets, and growing investment in stroke care technologies. Key trends expected include advancements in AI-powered diagnostic tools, ongoing innovations in neurorehabilitation, development of new thrombolytic medications, personalized stroke treatment approaches, and progress in regenerative therapy research.

The rising number of hypertension cases is expected to drive the growth of the stroke market in the coming years. Hypertension, or high blood pressure, occurs when the force of blood against artery walls remains consistently elevated. The increase in hypertension cases is largely attributed to rising obesity rates, as excess body weight puts additional strain on the heart and blood vessels, leading to higher blood pressure over time. Hypertension contributes to stroke by placing excessive pressure on blood vessel walls, which can result in the weakening, narrowing, or rupture of arteries in the brain. For example, in January 2025, the American Heart Association, a US-based nonprofit, reported 131,454 deaths primarily linked to high blood pressure in 2022. Additionally, in January 2024, the same organization reported 124,508 deaths primarily related to high blood pressure in 2021. Thus, the growing prevalence of hypertension is fueling the expansion of the stroke market.

Key players in the stroke market are concentrating on innovative stroke intervention technologies, such as flow-regulated large-bore access devices, to improve procedural accuracy and outcomes in complex neurovascular treatments like mechanical thrombectomy. Flow-regulated large-bore access involves a catheter design that combines a wide inner diameter for device delivery with integrated blood flow control, allowing for safer and more effective navigation during neurovascular procedures. For instance, in February 2025, Johnson & Johnson MedTech, a US-based medical technology firm, introduced the CEREGLIDE 92 Catheter System, a next-generation.092” catheter designed to enhance access and flow regulation during mechanical thrombectomy for acute ischemic stroke. This system aids physicians in navigating brain anatomy and restoring blood flow more efficiently. The device includes the INNERGLIDE 9 delivery aid for smooth catheter insertion and BRITE-LINE technology for improved visibility during procedures. Its TruCourse flexible tip facilitates navigation through complex cerebral vessels, boosting treatment success and patient outcomes, while also promoting sustainability through electronic instructions, reducing environmental impact.

In May 2025, Merck KGaA, a US-based science and technology company, acquired ApTOLL from aptaTargets for an undisclosed sum. Through this acquisition, Merck KGaA aims to broaden its neurology portfolio by advancing the development and commercialization of ApTOLL, an innovative therapy targeting acute ischemic stroke with the potential to reduce inflammation and brain damage, thereby improving patient outcomes. AptaTargets SL is a Spain-based biotechnology firm focused on developing novel treatments for acute neurological conditions, especially acute ischemic stroke.

Major players in the stroke market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Medtronic plc, Fresenius SE & Co. KGaA, Stryker Corporation, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals USA Inc., Daiichi Sankyo Company Limited, Amneal Pharmaceuticals LLC, Lupin Limited, MicroPort Scientific Corporation, Penumbra Inc., and NeuroVasc Technologies Inc.

North America was the largest region in the stroke market in 2024, and it is expected to be the fastest-growing region in the forecast period. The regions covered in stroke report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the stroke market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stroke market includes revenues earned by entities by providing services such as emergency medical services, imaging services, and blood pressure management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The stroke market research report is one of a series of new reports that provides stroke market statistics, including the stroke industry global market size, regional shares, competitors with the stroke market share, detailed stroke market segments, market trends, and opportunities, and any further data you may need to thrive in the stroke industry. This stroke market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Stroke is a severe medical emergency caused by a blockage or reduction in blood flow to a portion of the brain, which prevents the delivery of vital oxygen and nutrients to brain tissue. This interruption can cause brain cells to die within minutes, leading to sudden impairments like speech difficulties, paralysis, or cognitive dysfunction, and may result in lasting disability or death if immediate treatment is not administered.

The primary types of stroke include ischemic stroke, transient ischemic attack (TIA), and hemorrhagic stroke. Ischemic stroke occurs when a blood clot or other blockage obstructs blood flow to the brain, cutting off oxygen and nutrients. Various diagnoses and treatments are tailored for different gender groups, including male and female patients, and these services are distributed through channels such as direct providers, retail outlets, and online platforms. The main users of these services are hospitals and clinics.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.